A Novel Tolerogenic Antibody Targeting Disulfide-Modified Autoantigen Effectively Prevents Type 1 Diabetes in NOD Mice is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: AI153488, AI149655
NIAID NIH HHS
Grant: R21 AI149655
NIDDK NIH HHS
Grant: P30 DK116073
NIAID NIH HHS
Grant: R56 AI153488
NIAID NIH HHS
Grant: T32 AI074491
National Institutes of Health
Grant: 5P30DK116073-03
UC Denver Diabetes Research Center
National Institutes of Health
Grant: 5T32AI074491-12
Molecular Mechanisms of Immune Tolerance
National Institutes of Health
Grant: 1R56AI153488-01
Diabetogenic CD4 T Cell Recognition of Hybrid Peptide Ligands
National Institutes of Health
Grant: 1R21AI149655-01
T Cell Recognition of Disulfide Modified Antigens
National Institute of Diabetes and Digestive and Kidney Diseases
FWCI
0.51
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals